Literature DB >> 2941274

Monospecific antibodies reveal details of U2 snRNP structure and interaction between U1 and U2 snRNPs.

I W Mattaj, W J Habets, W J van Venrooij.   

Abstract

Monospecific antibodies directed against several U small nuclear ribonucleoprotein (U snRNP) particle proteins were affinity purified from a patient's anti-(U1,U2)RNP serum. These were used to demonstrate that: (i) proteins equivalent to the mammalian U2 snRNP-specific A' and B" proteins are present in Xenopus laevis oocytes; (ii) both proteins A' and B" have the same structural requirements for binding to U2 snRNA; (iii) proteins B, B' and D have the same structural requirement for binding to U2 snRNA; (iv) using very high specific activity RNA probes it is possible to detect a fraction of either U1 or U2 snRNA precipitable by antibodies directed against proteins specific for the other U snRNP, indicating an interaction between U1 and U2 snRNPs. The structural requirements of this interaction were studied for the U2 snRNP. All changes made to U2 snRNA or snRNP structure resulted in loss of the interaction with U1 snRNP.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2941274      PMCID: PMC1166893          DOI: 10.1002/j.1460-2075.1986.tb04314.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  34 in total

Review 1.  Snurps and scyrps.

Authors:  M R Lerner; J A Steitz
Journal:  Cell       Date:  1981-08       Impact factor: 41.582

2.  Isolation of small nuclear ribonucleoproteins containing U1, U2, U4, U5, and U6 RNAs.

Authors:  M Hinterberger; I Pettersson; J A Steitz
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

3.  SnRNAs, SnRNPs, and RNA processing.

Authors:  H Busch; R Reddy; L Rothblum; Y C Choi
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

4.  Structural organization of ribonucleoproteins containing small nuclear RNAs from HeLa cells. Proteins interact closely with a similar structural domain of U1, U2, U4 and U5 small nuclear RNAs.

Authors:  J P Liautard; J Sri-Widada; C Brunel; P Jeanteur
Journal:  J Mol Biol       Date:  1982-12-15       Impact factor: 5.469

Review 5.  U snRNA gene families in Xenopus laevis.

Authors:  I W Mattaj; R Zeller; A E Carrasco; M Jamrich; S Lienhard; E M De Robertis
Journal:  Oxf Surv Eukaryot Genes       Date:  1985

6.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Biochemical complementation with RNA in the Xenopus oocyte: a small RNA is required for the generation of 3' histone mRNA termini.

Authors:  G Galli; H Hofstetter; H G Stunnenberg; M L Birnstiel
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

8.  Human U1 and U2 small nuclear ribonucleoproteins contain common and unique polypeptides.

Authors:  C S Kinlaw; S K Dusing-Swartz; S M Berget
Journal:  Mol Cell Biol       Date:  1982-10       Impact factor: 4.272

9.  Fractionation and characterization of human small nuclear ribonucleoproteins containing U1 and U2 RNAs.

Authors:  C S Kinlaw; B L Robberson; S M Berget
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

10.  Nucleocytoplasmic distribution of snRNPs and stockpiled snRNA-binding proteins during oogenesis and early development in Xenopus laevis.

Authors:  R Zeller; T Nyffenegger; E M De Robertis
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

View more
  30 in total

1.  U1-U2 snRNPs interaction induced by an RNA complementary to the 5' end sequence of U1 snRNA.

Authors:  M C Daugeron; J Tazi; P Jeanteur; C Brunel; G Cathala
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

Review 2.  snRNPs and scRNPs as autoantigens: clues to the etiology of the connective tissue diseases.

Authors:  J Craft; M Mamula; Y Ohosone; G Boire; H Gold; J Hardin
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

3.  A weak interaction between the U2A' protein and U2 snRNA helps to stabilize their complex with the U2B" protein.

Authors:  W Boelens; D Scherly; R P Beijer; E J Jansen; N A Dathan; I W Mattaj; W J van Venrooij
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

4.  Modifications of U2 snRNA are required for snRNP assembly and pre-mRNA splicing.

Authors:  Y T Yu; M D Shu; J A Steitz
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

5.  Crosslinking of hnRNP proteins to pre-mRNA requires U1 and U2 snRNPs.

Authors:  S H Mayrand; T Pederson
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

6.  Association of U2 snRNP with the spliceosomal complex E.

Authors:  W Hong; M Bennett; Y Xiao; R Feld Kramer; C Wang; R Reed
Journal:  Nucleic Acids Res       Date:  1997-01-15       Impact factor: 16.971

7.  Direct, sequence-specific binding of the human U1-70K ribonucleoprotein antigen protein to loop I of U1 small nuclear RNA.

Authors:  C S Surowy; V L van Santen; S M Scheib-Wixted; R A Spritz
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

8.  Plant small nuclear RNAs. IV. The structure of U1 RNA from Chlorella saccharophila: a phylogenetic support, in terms of RNA structure, for the probable interaction between U1 and U2 and RNPs during the splicing of pre-mRNA.

Authors:  T Kiss; M Antal; H Hegyi; F Solymosy
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

9.  Are UsnRNA sequence variants involved in developmentally controlled, tissue-specific and/or alternative splicing of pre-mRNA at the level of RNA-protein interaction? Some hints from studies of plant systems.

Authors:  F Solymosy
Journal:  Mol Biol Rep       Date:  1990       Impact factor: 2.316

10.  U2 small nuclear RNA is remarkably conserved between Schizosaccharomyces pombe and mammals.

Authors:  P Brennwald; G Porter; J A Wise
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.